fringe sections of the society and often do not have timely access to appropriate healthcare. Endocrine abnormalities are increasingly been reported in patients with HIV infection, a likely result of improved clinical outcomes and increased survival due to highly active antiretroviral therapy (HAART) 3, 4 . We have reported thyroid dysfunction to be very common in patients with HIV infection with subclinical hypothyroidism being the predominant form observed in 14.76 per cent patients 3 . We have also reported hypogonadism to be a significant problem in HIV-infected men and women in India, effecting 39 and 29 per cent patients, respectively 4 .
Adrenocortical dysfunction is believed to be one of the common endocrinopathies in HIV 5, 6 . Autopsy studies have demonstrated adrenal involvement in 40-90 per cent of HIV-infected patients 7 .
Studies from Africa have consistently demonstrated a high prevalence of adrenal insufficiency (AI) in HIV-infected patients ranging from 27.5 to 34.5 per cent 8, 9 . However, AI/hypocortisolism is rarely diagnosed in routine clinical practice in patients with HIV infection in India. Non-specific clinical features (anorexia, nausea, weight loss, fatigue and hypotension), which are very common in patients with HIV infection, along with subclinical nature of the disease may explain this. Accurate and appropriate diagnosis of hypocortisolism is imperative, as both lack of diagnosis and treatment of hypocortisolism, as well as unnecessary use of glucocorticoids is associated with increased morbidity and mortality. The recent endocrine society clinical practice guideline recommends low threshold for screening for AI 10 . Screening for AI has been recommended in all patients with suggestive symptoms and signs as well as in acutely ill patients 10 . Further, no data are available on the burden of hypocortisolism in patients with HIV infection from India. Hence, this study was aimed to determine the presence, patterns and predictors of hypocortisolism/AI in patients with HIV infection in India. Patients with available CD4 cell counts at diagnosis and at first follow up (6-12 months after diagnosis) were included in the study. The study protocol was explained to the considered patients and only those who gave informed written consent were included in this study. The institutional ethics committee approved the study protocol.
Material & Methods
Sample collection: All patients underwent detailed clinical assessment. The patients were called the subsequent day in fasting state for blood sampling. Blood samples (5 ml) were collected in plain and ethylenediaminetetraacetic acid (EDTA) vacutainers (Becton Dickinson, USA) between 8 and 9 am in the morning. Serum was separated from blood collected in plain vacutainer and processed immediately for routine biochemical analysis, and one aliquot of serum was stored at −20°C. EDTA sample processed for haematological analysis. . Patients with post-ACTH cortisol ≥18 µg/dl (500 nmol/l) were defined to have normal adrenal reserve. Patients with post-ACTH cortisol <18 µg/dl (500 nmol/l) were defined to have AI (hypocortisolism).
Immune reconstitution inflammatory syndrome (IRIS) has been defined as an increased CD4 count above 200 cells/µl in patients who previously had <100-200 cells/µl of CD4 counts 12, 13 . Hence, patients in our study with baseline CD4 counts <200 cells/µl, which increased to >200 cells/µl at the first follow up following initiation of HAART were defined to have IRIS.
Sample size calculation:
The prevalence of AI among HIV patients in India is not known. However, studies done in South Africa and Nigeria have shown 27.5 and 34.5 per cent of HIV positive patients had AI, respectively 8, 9 . Keeping a power of 80 per cent and Type-I error at 5 per cent, a sample size of 246 patients was required in our study for accurate assessment of hypoadrenalism.
Statistical analysis: Normality of the distribution of variables was checked using the KolmogorovSmirnov test. All normally distributed variables have been elaborated as mean±standard deviation. All nonnormally distributed variables have been mentioned as median (range). Range is a measure of the deviation of the variable and was calculated as the difference between the highest and the lowest value of the variable. Independent t test and Wilcoxon rank-sum test were done for normally distributed and skewed variables, respectively. Chi-square test was used for categorical variables. Multiple logistic regression analyses were done to determine variables that independently influenced the occurrence of hypoadrenalism after adjusting for factors in different models. Statistical Package for the Social Sciences (SPSS) version 20 (Chicago, IL, USA) was used for data analysis.
Results
Five hundred and twenty seven consecutive patients were screened, of whom 359 patients (225 males and 134 females) who fulfilled the inclusion and exclusion criteria and gave informed written consent were included in this study (Figure) A total of 283 patients had morning cortisol <18 µg/dl (500 nmol/l). Of these, 13 patients (3.62%) had morning cortisol <6 µg/dl (<165 nmol/l) (Group 1), 71 (19.24%) had morning cortisol between 6 and 11 µg/dl (165-300 nmol/l) (Group 2) and 199 (55.43%) had morning cortisol between 11 and 18 µg/dl (300-500 nmol/l) (Group 3). Seventy six patients (21.17%) had morning cortisol ≥18 µg/dl (500 nmol/l) (Group 4). ACTH stimulation test revealed 87 patients (24.23%) to have one hour post-ACTH cortisol to be <18 µg/dl (<500 nmol/l) who were diagnosed to have AI (hypocortisolism). The increments in serum cortisol levels post-ACTH stimulation as compared to morning basal cortisol (Δ cortisol) [median (range)] in Groups 1, 2, 3 and 4 were 118 (288.5), 209 (474.9), 194 (1106) and 224 (549) nmol/l, respectively, which was significantly different (P<0.05). The presence of AI (hypocortisolism) in patients with baseline morning cortisol <6 µg/dl (165 nmol/l), 6-11 (165-300 nmol/l), 11-18 (300-500 nmol/l) and ≥18 µg/dl (500 nmol/l) was 100 per cent (13/13 patients), 56.34 per cent (40/71 patients), 17.09 per cent (34/199 patients) and 0 per cent (0/76 patients), respectively (Table II) .
Both basal morning cortisol and dehydroepiandrosterone sulphate (DHEAS) were significantly lower in females as compared to males (P<0.01) (Table III) . In our study, patients with AI had significantly longer disease duration (P<0.05). Diabetes and prediabetes were observed in seven (1.95%) and 26 (7.24%) patients (Table I ). The occurrence of diabetes was significantly lower in patients with AI (Table I) . Patients with AI had significantly higher serum potassium (P<0.05) and lower fasting blood glucose (P=0.01), (Table IV) . Two and six patients with AI had evidence of hypoglycaemia and hyperkalaemia, respectively (Table IV) . Majority of the patients with AI had morning cortisol between 6 and 11 µg/dl (165-300 nmol/l) (Table II) .
Basal and post-ACTH stimulation cortisol levels had no correlation with CD4 counts. One-hour post-ACTH stimulation but not basal cortisol had significant positive correlation with DHEAS (σ=0.213; P=0.025). Binary logistic regression analysis revealed that basal morning cortisol and serum DHEAS to be the two best independent predictors of AI among patients with HIV infection (P=0.004 and 0.028, respectively) ( Table V) .
Discussion
The entire spectrum of hypothalamic-pituitaryadrenal (HPA) axis dysfunction has been reported in HIV ranging from normal to high basal cortisol levels with blunt response to ACTH, a state of glucocorticoid resistance characterized by features of AI with high circulating levels of glucocorticoids to frank hypocortisolism/ AI 14 . Hypocortisolism usually occurs only after >80 per cent of the adrenal gland been destroyed 15 .
High baseline cortisol >18 µg/dl (500 nmol/l) was observed in 21.17 per cent patients in our study who had an intact adrenal response to ACTH stimulation. One group has reported hypercortisolaemia in HIV with blunted ACTH and cortisol response to stress and corticotropinreleasing hormone, especially in patients with advanced disease 16 . Increased systemic inflammation (increased circulating levels of cytokines) is believed to stimulate adrenal glucocorticoid synthesis 16, 17 . Increased circulating cortisol binding globulin levels may also contribute to the hypercortisolaemia in HIV infection 18 . Hypercortisolism was observed in patients with advanced disease and increased viraemia 19 . HIV envelope protein gp-120 has been linked to induction of HPA axis hyperactivity 19 . Stable clinical condition with good immune function (90.25% patients had CD4 cell count >200 cells/µl) may explain the intact adrenal response to ACTH stimulation in patients with basal hypercortisolaemia observed in our study. HIV viral load was not assessed and is a limitation of this study. Lack of estimation of ACTH and levels of inflammatory cytokines are also a limitation.
AI was seen in 24.23 per cent patients, which was comparable to previous reports from other parts of the globe. Studies from Brazil, Uganda, South Africa and † Viral infections include hepatitis-B, hepatitis-C and others. AZT, 3TC, d4T and/or TDF were the NRTIs received by the patients; NVP or EFV was NNRTIs received by the patients; ATV or RTV was the PI received the patients. HAART, highly active antiretroviral therapy; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-NRTIs; PI, protease inhibitor; IRIS, immune reconstitution inflammatory syndrome; BMI, body mass index; SD, standard deviation; AZT, zidovudine; 3TC, lamivudine; d4T, stavudine; TDF, tenofovir; NVP, nevirapine; EFV, efavirenz; ATV, atazanavir; RTV, ritonavir; HIV, human immunodeficiency virus 8, 9, 20, 21 . In a small study of critically ill AIDS patients with advanced disease from southern India (n=50), AI was diagnosed in 74 per cent patients using ACTH stimulation test 22 , which was much higher than that in this report. However, it must be highlighted that patients in our study were clinically stable, asymptomatic with good immune function. It is important to highlight that none of the patients diagnosed with AI in this study had hyperpigmentation or postural hypotension. However, patients with AI had significantly higher serum potassium and lower fasting blood glucose. Plasma ACTH was not measured in this study. Hence, it was not possible to differentiate primary from secondary AI in this study, which is a limitation of this study.
The presence of vitamin-D insufficiency [25(OH)D <30 ng/ml] among HIV-infected patients in our study was 89.69 per cent, which was higher than that observed in the general Indian population (70-75%) 23, 24 . Several pleotropic functions have been attributed to vitamin-D including its impact on immune function, autoimmunity, insulin resistance and cardiovascular function 25, 26 . Vitamin D deficiency has been linked with more rapid decline in CD4 cell count, higher occurrence of osteoporosis, cardiovascular disease, diabetes, autoimmune disease and cancer in HIV-infected patients 27, 28 . Vitamin-D receptor gene polymorphism has been linked to increased occurrence of AI 29 . Hence, further studies are needed to evaluate the link between vitamin D and hypocortisolism. 30, 31 . A reduced DHEAS/cortisol ratio has been reported to be associated with a deterioration of immune status characterized by a shift from Th1-to a Th2-driven immune response 30 . Reduced DHEAS levels, accompanied by increased cortisol levels, were observed in patients with AIDS wasting syndrome 31 . This is believed to be a result of shift of steroid metabolism from adrenal androgens to glucocorticoids in patients with advanced HIV infection 31 . A decreased adrenal 17,20-lyase activity may explain this phenomenon 30, 31 . In our study, patients with AI had lower DHEAS levels and low serum DHEAS was an independent predictor of increased risk for AI in patients with HIV infection. The occurrence of dysglycaemia among patients with HIV infection in our study [diabetes (1.95%) and prediabetes (7.24%)] was not increased as compared to the occurrence rates in the general population in India 32, 33 . In large cross-sectional studies, the prevalence rates of diabetes among HIV-infected patients from Cameroon, Guinea-Bissau and Italy were reported to be 3.8 per cent (n=500), 5.8 per cent (n=953) and 4.5 per cent (n=755), respectively [34] [35] [36] . There are conflicting reports with a few, but not all studies reporting increased prevalence of diabetes in HIV infected patients [34] [35] [36] [37] . A study from Spain documented lower insulin resistance and lower incidence of diabetes in HIVinfected patients on ART 37 . In our study, the decreased occurrence of diabetes among HIV-infected patients with AI can be explained by the physiologic role of cortisol in increasing blood glucose through increased glycogenolysis and gluconeogenesis 38 . Low cortisol levels in AI is known to have a favourable impact on blood glucose values, which also explains the increased occurrence of hypoglycaemia in these patients 38 .
In conclusion, AI is a significant problem in HIV-infected patients in India with stable clinical and immune function, observed in nearly a quarter of the patients. Diagnosis of AI in HIV requires a high index of suspicion, as the typical symptoms associated with AI are usually absent. A low threshold of screening is advisable, especially in patients with low serum DHEAS and hyperkalaemia. Morning basal cortisol is a good screening test, with ACTH stimulation warranted to confirm diagnosis, especially in patients with morning cortisol <11 µg/dl (300 nmol/l). Low basal morning cortisol and DHEAS were the two predictors of AI. All patients with morning cortisol <6 µg/dl (165 mmol/l) and more than half of the patients (61%) with morning cortisol <11 µg/dl (300 nmol/l) had AI. 
